Fwd: SynBioBeta Digest #17

6 views
Skip to first unread message

Ryan Bethencourt

unread,
Apr 1, 2014, 8:28:53 PM4/1/14
to berkeley...@googlegroups.com


---------- Forwarded message ----------
From: Lisa Comeau <lisa....@synbiobeta.com>
Date: Tue, Apr 1, 2014 at 4:10 PM
Subject: SynBioBeta Digest #17
To: ryan.bet...@gmail.com


Gmail users – Don't Miss Your Digest!
Drag this email to your Primary inbox tab and click "yes".
You can’t see this email? View it in your browser.

 Digest #17
We share news and views from the growing synthetic biology industry

Next Leap in Synthetic Life: The First Synthetic Yeast Chromosome

Scientists, including undergraduates, have synthesized the first fully functional chromosome from the baker's yeast Saccharomyces cerevisiae. This work paves the way for a new era of biology based on the redesign of genomes.

Synbiota Honoured at SXSW 6th Annual Accelerator Competition

Synbiota takes the top prize in the Innovative World Technologies category.

The Search for High Oleic Oils — By Doris de Guzman

How the market for high oleic oils is being developed in Australia, US and Canada.

How Autodesk’s Project Cyborg Will Revolutionize Synthetic Biology

How Project Cyborg will reshape the “Design, Build, Test” cycle and change how we think about biology.

Will Genome Compiler & DNA2.0 Settlement Bring Relief to SynBio Industry?

What does it mean for the future of bioCAD software platforms and the industry at large?

Oxbridge Biotech Editorial: Steve Bates on UK Biotechnology

UK offers a strong science base, investors, skilled workforce and government support for biotech.

Luke Alphey Named BBSRC Innovator of the Year 2014

Luke has been recognized for his work on the genetic control of pest insects at Oxitec Ltd.

MIT SBC and Pfizer to Work on Drug Discovery and Development

Three-year collaboration spans multiple areas at Pfizer and involves several investigators at MIT SBC.

5 Considerations for SynBio Investors — By Jamie Bacher

Investors need new models, financial and heuristic, to evaluate investment opportunities in synbio.

Don’t Get Hung Up On Gene Synthesis — By Markus Gershater

We should now focus on the bigger problem of effectively addressing biological complexity.

Founders Fund Closes $1 billion in Financing for New Venture-Capital Fund

Firm aims to fund companies that are passionate about addressing the world’s most critical problems.

How Synthetic Biology is Exploring Biological Complexity

Sean Ward joins TEDxVilnius to spread his message about the future of genetic engineering.

DNA Editing Tools Are Opening the Door to Custom-Made Genomes

CRISPR and other technologies could let scientists precisely delete and edit specific sequences of DNA.

Job Postings
Have some news for the next SynBioBeta Digest? Contact Lisa Comeau.

        

 
Copyright © 2014 SynBioBeta, All rights reserved

unsubscribe from this list    update subscription preferences



--
Reply all
Reply to author
Forward
0 new messages